Hot Features
CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs. Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherap... CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs. Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues. The company also offers formulation and consultancy services. The company was formerly known as Amur Minerals Corporation and changed its name to CRISM Therapeutics Corporation in May 2024. CRISM Therapeutics Corporation was founded in 2016 and is based in Road Town, the British Virgin Islands. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.25 | -2.38095238095 | 10.5 | 10.5 | 10.25 | 295520 | 10.39076956 | DE |
| 4 | -0.5 | -4.6511627907 | 10.75 | 11.5 | 10.25 | 276837 | 10.74794202 | DE |
| 12 | -1.5 | -12.7659574468 | 11.75 | 13 | 10.25 | 188775 | 11.35488893 | DE |
| 26 | 0.75 | 7.89473684211 | 9.5 | 18.25 | 9 | 268202 | 12.48808298 | DE |
| 52 | -13.25 | -56.3829787234 | 23.5 | 23.5 | 8 | 173079 | 12.06504048 | DE |
| 156 | -13.75 | -57.2916666667 | 24 | 30.5 | 5.25 | 118628 | 12.87307237 | DE |
| 260 | -13.75 | -57.2916666667 | 24 | 30.5 | 5.25 | 118628 | 12.87307237 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.